Fifth Third Bancorp
HQL

Fifth Third Bancorp’s abrdn Life Sciences Investors HQL Stock Holding History

Fifth Third Bancorp’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.2K Buy
+874
New +$14.6K ﹤0.01% 3607
2022
Q2 		– Sell
-5
Closed – – 2713
2022
Q1 		$0 Buy
5
+3
+150% +$52 ﹤0.01% 2717
2021
Q4 		$0 Hold
2
– – ﹤0.01% 2723
2021
Q3 		$0 Hold
2
– – ﹤0.01% 2693
2021
Q2 		$0 Hold
2
– – ﹤0.01% 2470
2021
Q1 		$0 Sell
2
-114
-98% -$2.35K ﹤0.01% 2448
2020
Q4 		$2K Buy
+116
New +$2.14K ﹤0.01% 2224
2015
Q1 		– Sell
-1,104
Closed -$27K – 2829
2014
Q4 		$27K Buy
1,104
+20
+2% +$480 ﹤0.01% 1625
2014
Q3 		$24K Buy
1,084
+20
+2% +$434 ﹤0.01% 1702
2014
Q2 		$22K Buy
1,064
+542
+104% +$11.4K ﹤0.01% 1773
2014
Q1 		$11K Buy
522
+9
+2% +$200 ﹤0.01% 1964
2013
Q4 		$10K Hold
513
– – ﹤0.01% 1835
2013
Q3 		$10K Buy
+513
New +$9.82K ﹤0.01% 1871

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fifth Third Bancorp's HQL Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in abrdn Life Sciences Investors (HQL) in Q1 2026: 874 shares worth $14.2K. The stake represents ﹤0.01% of the portfolio and ranks #3607 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in HQL as recently as Q1 2022.

Fifth Third Bancorp first reported a position in HQL in Q3 2013 and has held it in 13 quarters since. The position peaked at $27K in Q4 2014. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Fifth Third Bancorp held 874 shares of abrdn Life Sciences Investors worth $14.2K as of Q1 2026.
  • abrdn Life Sciences Investors was a new Fifth Third Bancorp position in Q1 2026.
  • abrdn Life Sciences Investors made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3607 holding.
  • Fifth Third Bancorp first reported a position in abrdn Life Sciences Investors in Q3 2013 and has held it in 13 quarters since.
  • Fifth Third Bancorp's abrdn Life Sciences Investors position peaked at $27K in Q4 2014.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.